Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2409852122Source: DataRank Database

Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis is a research paper published in Proceedings of the National Academy of Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

geo nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 2.18)OA: hybridTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Kevin R. Hughes ORCID,Sydney N. Wheeler ORCID,Joseph T. Decker ORCID,Sophia M. Orbach ORCID,Angelica Rose Galvan ORCID

Live enrichment

PubMed:39937858 PMC:PMC11848328 OpenAlex:https://openalex.org/W4407402897

HHS | NIH | National Institute of Biomedical Imaging and Bioengineering

Grant: R00EB028840

HHS | NIH

Grant: 1R01AI155678

HHS | NIH

Grant: 1R01CA243916

HHS | NIH

Grant: R01CA272940

NIDDK NIH HHS

Grant: T32 DK071212

NCI NIH HHS

Grant: P30 CA046592

NIAID NIH HHS

Grant: R01 AI155678

NIDCR NIH HHS

Grant: T32 DE007057

NCI NIH HHS

Grant: R01 CA243916

FWCI

2.18

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://www.pnas.org/doi/pdf/10.1073/pnas.2409852122

publisherhttps://www.pnas.org/doi/pdf/10.1073/pnas.2409852122

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2409852122

journalhttps://doi.org/10.1073/pnas.2409852122

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39937858

Fields of Study

Immunotherapy and Immune ResponsesRNA Interference and Gene DeliveryMultiple Sclerosis Research StudiesAnimalsMiceDisease Models, AnimalNanoparticlesMultiple SclerosisMultiple Sclerosis, Chronic ProgressiveHumansBiocompatible MaterialsFemaleMice, Inbred C57BL

MeSH Terms

AnimalsBiocompatible MaterialsDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalFemaleHumansMice, Inbred C57BLMultiple SclerosisMultiple Sclerosis, Chronic ProgressiveMiceNanoparticles

Keywords

Immune systemMultiple sclerosisImmunologyChemokineAntigenMedicineBiologyAutoimmunityBiomaterialsRegenerative MedicineImmunoengineering

Sustainable Development Goals

SDG 0: Good health and well-being

Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis

FAIR Checklist

Authors (13)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)